Clinical Trial Update: Supplementation With L-ornithine But Not L-arginine Increases Density of CD68+ and CD163+ Macrophages in Periodontitis [Phase 3]

View source ↗

Summary

A Phase 3 trial assesses supplementation with L-ornithine (but not L-arginine) and its effect on macrophage densities in periodontitis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• L-Arginine (L-Arginine)
• L-ornithine (L-ornithine)

Snippet

Sponsor: Ukrainian Medical Stomatological Academy | Conditions: Periodontitis | Phase 3 | Status: COMPLETED